Merck logo

Principal Scientist, Translational Medicine, Neuroscience

Merck

West Point, PA; Boston, MA; Rahway, NJHybridPosted 1 day ago$255,800.00 - $402,700.00
Full TimeSenior LevelClinical DevelopmentPharmaceutical
Original posting ↗

Summary

We have an exciting opportunity for a physician-scientist to join our group as a Principal Scientist (Clinical Director) in Translational Medicine/Early Clinical Development in the Neuroscience Therapeutic Area based in the US. Translational Medicine at our Research Division is responsible for early clinical development of novel therapeutics, working in close collaboration with our discovery scientists and late-stage clinical researchers. The Neuroscience Therapeutic Area specifically focuses on diseases affecting the central and peripheral system.

Job description

The ideal candidate for this position is a physician-scientist with training in neurology or psychiatry and an established track record of scientific achievement, who desires a career in developing therapies for neurologic and psychiatric disease. Candidates should have a strong background in basic, translational, and/or clinical research and a desire to work collaboratively across the organization between departments and therapeutic areas as part of a global team.

Primary Responsibilities

  • Working with basic science teams on specific diseases and therapeutic areas, providing clinical expertise for identification and validation of novel targets, including the design of preclinical and clinical experiments to validate targets and/or pathways, and leveraging this work for development of novel therapeutics
  • Working with cross-functional teams including discovery scientists, pharmacologists, toxicologists, and other specialists to advance novel therapeutics from preclinical development into clinical development
  • As a key member/leader of an early development team, working in close collaboration with internal and external staff and scientists (including discovery research, biostatistics, drug metabolism, modeling and simulation, regulatory affairs, and global clinical trials operations) for the design and execution of early clinical development strategy
  • Taking a lead role in developing and executing clinical pharmacology studies for programs in all phases (I – IV) of development, including formulation or device changes, drug-drug interaction studies, and studies in special populations
  • Providing early phase/clinical pharmacology support for programs through the regulatory filing process including preparation of supportive documents and presentations
  • Developing and executing studies to validate established and novel clinical biomarkers, including blood/tissue sampling, imaging, electrophysiological, wearable devices, and behavioral responses to study biological activity in humans
  • Providing clinical and scientific expertise to assess internal and external opportunities for partnership
  • Engaging with the broader internal and external scientific community in disease or therapeutic areas of interest, including via consultations with scientific/academic thought leaders, preparation of posters and publications, and attendance/presentation at conferences
  • Working broadly with key functions across the company at research sites around the world

Translational Medicine Responsibilities

  • Contributing to the identification of novel targets by partnering with Discovery Sciences to bring a clinical perspective into the earliest stages of target identification and validation, and to execute clinical studies to evaluate the relevance of potential targets to human disease in order to justify full development
  • Leadership of the early clinical development strategy for novel therapeutic programs from the preclinical stage through Phase 1 studies of safety, tolerability, pharmacokinetics and pharmacodynamics, to Phase 2 studies demonstrating Proof-of-Concept and enabling Phase 3 clinical trials
  • Development of biomarker strategies through cross-functional teams that advance therapeutics from First-in-Human studies through clinical Proof-of-Concept, including experimental medicine studies to establish and/or validate biomarker platforms
  • Development and execution of clinical pharmacology strategies to support later stages of development through to worldwide regulatory applications

Requirements

  • Doctoral degree: MD or MD/PhD (or international equivalent) required
  • Experience in biomedical research, with a demonstrated record of scientific scholarship and achievement including scientific publications
  • Strong interpersonal, writing, and presentation skills
  • Ability to function in a team environment
  • Experience in clinical medicine including completion or anticipated completion of residency training
  • Biomedical Research
  • Clinical Development
  • Clinical Medicine
  • Clinical Research
  • Clinical Trial Planning
  • Cross-Functional Teamwork
  • Neuroscience Research
  • Neurologic Disorders
  • Translational Research
  • Early Clinical Development
  • Neurodegenerative Diseases
  • Neurological Disorders
  • Neuroscience
  • Translational Medicine

Benefits

  • Medical, Dental & Vision
  • Retirement Benefits
  • 401(k)
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.